Healthcare leaders weigh in on wearable technologies
Identifying devastating cardiac events before a patient feels pain is becoming a reality and healthcare leaders, researchers and business leaders...
Center for Preclinical Surgical & Interventional Research
Science features liquid electrodes
Texas Heart Institute (THI) physician-scientist and innovator, Mehdi Razavi, MD, Director of THI’s Electrophysiology Clinical Research & Innovations and Fellow...
New Technology Could Mitigate Post-Operative Atrial Fibrillation
A preclinical research study from the Texas Heart Institute further validated a new technology developed by NativeCardio designed to mitigate postoperative atrial fibrillation (POAF): a critical...
An Artificial Heart Game Changer: Dubaieye Radio Podcast Interview with THI Surgeon Inventor Dr. Billy Cohn
DubaiEye Radio 103.8 interviewed Texas Heart Institute’s renowned surgeon and medical device inventor, Dr. Billy Cohn, about how he and Dr....
Scientific Papers Take Our Research to the World
Since its creation in 1962, Texas Heart Institute has been a leader in advancing cardiovascular medicine, making discoveries that have...
Celebrating the Top Stories of 2021
As everyone is reflecting on the year and looking forward to 2022, we celebrate the best stories, news and milestones....
Alternative Metrics Reveal THI’s Most Popular Scientific Articles from 2021
The impact of a scientific article is often described in terms of how many times the article has been cited...
Dr. Darren Woodside – Texas Heart Institute Vice President for Research – Receives Heralded Fellow Designation by the National Academy of Inventors
HOUSTON, TX (DECEMBER 7, 2021) – The Texas Heart Institute is pleased to announce that Dr. Darren G. Woodside, Senior...
Reimagining the Future of Cardiovascular Health
When Dr. Denton Cooley and his colleagues founded the Texas Heart Institute (THI), it was with the firm belief that excellence in...
Texas Heart Institute Unites To Promote Cardiovascular Health on World Heart Day
Cardiovascular disease (CVD) remains the world’s number one killer, resulting in 18.6 million deaths a year. From well-known risk factors...
A New Documentary Chronicles the Development of the Permanent Artificial Heart
This summer, both doctors and multimedia and communications specialists at the Texas Heart Institute (THI) worked with award-winning New York-based...
Groundbreaking Cardiovascular Gene Therapy Has Potential to Drastically Alter Outlook for Heart Failure Patients
Published in Science Translational Medicine – A Revolutionary New Game Plan for Treating Individuals Following a Heart Attack HOUSTON, TX...
